AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ROCKET PHARMACEUTICALS, INC. Director's Dealing 2025

Feb 25, 2025

33148_dirs_2025-02-25_f6827f48-3ac9-4ba8-b39b-0a6b39735da9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2025-02-21

Reporting Person: Shah Gaurav (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-21	Common Stock	S	16303	$10.58	Disposed	772680	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	207897	Indirect
Common Stock	198341	Indirect

Footnotes

F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.

F2: The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.